Inventor · disambiguated record
Ying Liu
Also filed as: LIU YING · LIU YING CHIH
18 granted patents·6 pending applications·307 citations·filing 1993–2021
94Inventor score
Files withSCHERING CORP5WEBER RICHARD5AMGEN FREMONT INC4Xuzhou Central Hospital2BEIJING KAWIN TECH SHARE HOLDING CO LTD1
Top patents by PatentIndex Score
24 records- 0197US7736644B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Jun 15, 2010·77 cites·115 claims
- 0297US7628986B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2004·Granted Dec 8, 2009·119 cites·83 claims
- 0393US9096672B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Aug 4, 2015·16 cites·38 claims
- 0488US9062113B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jun 23, 2015·7 cites·28 claims
- 0586US5789192AMammalian receptors for interleukin-10 (IL-10)SCHERING CORP·Filed 1993·Granted Aug 4, 1998·45 cites·21 claims
- 0682US9073998B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Jul 7, 2015·3 cites·88 claims
- 0781US11492411B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2019·Granted Nov 8, 2022·0 cites·20 claims
- 0881US10118968B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2009·Granted Nov 6, 2018·2 cites·54 claims
- 0980US9085624B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofWEBER RICHARD·Filed 2008·Granted Jul 21, 2015·2 cites·26 claims
- 1079US5863796AAntibodies which specifically bind mammalian receptors for interleukin-10 (IL-10)SCHERING CORP·Filed 1995·Granted Jan 26, 1999·24 cites·25 claims
- 1175US10508153B2Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereofAMGEN FREMONT INC·Filed 2015·Granted Dec 17, 2019·1 cites·61 claims
- 1271US9957564B2Application of a PCR sequencing method, based on DNA barcoding technique and DNA incomplete shearing strategy, in HLA genotypingLI JIAN·Filed 2011·Granted May 1, 2018·1 cites·20 claims
- 1368US6824781B2Method of impairing movement of a CLA + memeory T-cell within or to the skin of a mammal by administering a CTACK antagonistSCHERING CORP·Filed 2001·Granted Nov 30, 2004·2 cites·13 claims
- 1458US12421305B2Antibody for enrichment of cellsCHO PHARMA INC·Filed 2021·Granted Sep 23, 2025·0 cites·7 claims
- 1557US12180304B2Variable region sequence of broad-spectrum antibody against clothianidin and dinotefuran and preparation of intact recombinant antibody thereofUNIV ZHEJIANG·Filed 2021·Granted Dec 31, 2024·0 cites·9 claims
- 1657US11885804B2Application of ERH gene in the preparation of bladder cancer diagnosis and treatment productsXuzhou Central Hospital·Filed 2021·Granted Jan 30, 2024·0 cites·3 claims
- 1755US2023265168A1Antibody binding to hepatitis b virus surface antigen and application of antibodyBEIJING KAWIN TECH SHARE HOLDING CO LTD·Filed 2021·Application pending·0 cites
- 1850US2022170940A1Biomarker with therapeutic implications for peritoneal carcinomatosisSINGAPORE HEALTH SERV PTE LTD·Filed 2020·Application pending·0 cites
- 1946US5985828AMammalian receptors for interleukin-10 (IL-10)SCHERING CORP·Filed 1995·Granted Nov 16, 1999·6 cites·23 claims
- 2039US6423500B1Mammalian receptors for interleukin-10SCHERING CORP·Filed 1999·Granted Jul 23, 2002·2 cites·3 claims
- 2138US2018119171A1Replicative vaccinia virus vector hiv vaccineNAT CENTER FOR AIDS/STD CONTROL AND PREVENTION CHINESE CENTER FOR DISEASE CONTROL·Filed 2018·Application pending·0 cites
- 2237US2010034851A1AIDS Vaccine Based on Replicative Vaccinia Virus VectorSHAO YIMING·Filed 2007·Application pending·0 cites
- 2334US2019339276A1Application of ERH Gene in the Preparation of Bladder Cancer Diagnosis and Treatment ProductsXuzhou Central Hospital·Filed 2017·Application pending·0 cites
- 2433US2019391167A1Method for predicting the development of type 2 diabetesGOVERNING COUNCIL UNIV TORONTO·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ying Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →